M
Mubadala Capital
Focus: AI, Healthtech & bioMubadala Capital took part in 2 of the startup funding rounds we tracked in 2026, leading or co-leading 1 worth $3.9bn. By money raised, its biggest sectors were AI and Healthtech & bio. The largest was Crusoe's $3.9bn Series D+ round. The most recent was Precision Neuroscience's Series D+ round in September 2026.
Deployed as lead$3.9bn
Rounds led1
Rounds joined2
Largest round$3.9bn